Health Results Based Financing Impact Evaluation 2014, Health Facility Baseline Survey

Tajikistan, 2014 - 2015

Get Microdata

Reference ID

TJK_2014_HRBFIE-FBL_v01_M

DOI

https://doi.org/10.48529/s143-rw94

Producer(s)

Damien de Walque, Aneesa Arur, Gil Shapira

Collection(s)

Impact Evaluation Surveys

Metadata

Documentation in PDF DDI/XML JSON

Created on

Mar 30, 2017

Last modified

Mar 30, 2017

Page views

193463

Downloads

13607

ANTI-HYPERTENSIVE DRUG TREATMENT (V6_3_1)

Data file: f22_hh

Overview

Valid: 323

Invalid: 0

Minimum: 1

Maximum: 2

Type: Discrete

Decimal: 0

Start: 1149

End: 1149

Width: 1

Range: 1 - 2

Format: Numeric

Questions and instructions

Question pretext

PLEASE READ THE RESPONDENT CARD #3 OF THE CASE SCENARIO 6 Let's assume that level of the risk of CVD of Otabek identified as -20 - 30% high risk(3)

Literal question

Assuming that all the needed drugs are in stock in the health facility. What are the all actions you would undertake and/or prescriptions you would write to provide Otabek with the most appropriate treatment? CIRCLE ALL THAT APPLY
PRESCRIBE: ANTI-HYPERTENSIVE DRUG TREATMENT

Value	Category	Cases
1	MENTIONED	205	63.5%
2	NOT MENTIONED	118	36.5%